The store will not work correctly when cookies are disabled.
3-{[(7-Methoxy-3-methyl-1-benzothien-2-yl)sulfonyl]amino}benzoic acid
ID: ALA3727631
PubChem CID: 56941308
Max Phase: Preclinical
Molecular Formula: C17H15NO5S2
Molecular Weight: 377.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc2c(C)c(S(=O)(=O)Nc3cccc(C(=O)O)c3)sc12
Standard InChI: InChI=1S/C17H15NO5S2/c1-10-13-7-4-8-14(23-2)15(13)24-17(10)25(21,22)18-12-6-3-5-11(9-12)16(19)20/h3-9,18H,1-2H3,(H,19,20)
Standard InChI Key: DZUYGSSDBJXOIB-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
3.6387 -0.8963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4133 -1.7530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5871 -1.5034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3114 -2.9665 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5523 -4.4208 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.9520 -5.4598 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.1518 -5.4603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0532 -4.4218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.8036 -5.7215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.3036 -5.7247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.0509 -7.0252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2983 -8.3228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7983 -8.3197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0509 -7.0191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0425 -9.6164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8426 -9.6122 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.6386 -10.6579 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
10 11 1 0
11 12 1 0
12 3 1 0
12 7 2 0
10 13 1 0
13 14 2 0
13 15 2 0
13 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
21 23 1 0
23 24 2 0
23 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 377.44 | Molecular Weight (Monoisotopic): 377.0392 | AlogP: 3.72 | #Rotatable Bonds: 5 |
Polar Surface Area: 92.70 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.96 | CX Basic pKa: ┄ | CX LogP: 3.52 | CX LogD: -0.32 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.71 | Np Likeness Score: -0.96 |
References
1. (2012) New compounds, |
2. (2016) Sulfonamide compounds, |